v3.26.1
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   30,663,000    
Balance at beginning of period at Dec. 31, 2024 $ 93,989 $ 3 $ 750,174 $ (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,054   3,054  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   3,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   156,000    
Issuance of common stock (in shares)   592,000    
Issuance of common stock 5,111   5,111  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (58,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (492)   (492)  
Net loss (12,813)     (12,813)
Balance at end of period (in shares) at Mar. 31, 2025   31,356,000    
Balance at end of period at Mar. 31, 2025 88,849 $ 3 757,847 (669,001)
Balance at beginning of period (in shares) at Dec. 31, 2024   30,663,000    
Balance at beginning of period at Dec. 31, 2024 93,989 $ 3 750,174 (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (54,052)      
Balance at end of period (in shares) at Jun. 30, 2025   34,557,000    
Balance at end of period at Jun. 30, 2025 86,560 $ 3 796,797 (710,240)
Balance at beginning of period (in shares) at Mar. 31, 2025   31,356,000    
Balance at beginning of period at Mar. 31, 2025 88,849 $ 3 757,847 (669,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,599   3,599  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   32,000    
Issuance of common stock upon exercise of stock options 180   180  
Issuance of common stock upon vesting of restricted stock units (in shares)   139,000    
Issuance of common stock (in shares)   3,081,000    
Issuance of common stock 35,766   35,766  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (51,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (595)   (595)  
Net loss (41,239)     (41,239)
Balance at end of period (in shares) at Jun. 30, 2025   34,557,000    
Balance at end of period at Jun. 30, 2025 $ 86,560 $ 3 796,797 (710,240)
Balance at beginning of period (in shares) at Dec. 31, 2025 35,930,000 35,930,000    
Balance at beginning of period at Dec. 31, 2025 $ 94,875 $ 4 821,319 (726,448)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 4,421   4,421  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   9,000    
Issuance of common stock upon exercise of stock options 7   7  
Issuance of common stock upon vesting of restricted stock units (in shares)   324,000    
Issuance of common stock (in shares)   631,000    
Issuance of common stock 14,204   14,204  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (127,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (3,039)   (3,039)  
Net loss (29,663)     (29,663)
Balance at end of period (in shares) at Mar. 31, 2026   36,767,000    
Balance at end of period at Mar. 31, 2026 $ 80,805 $ 4 836,912 (756,111)
Balance at beginning of period (in shares) at Dec. 31, 2025 35,930,000 35,930,000    
Balance at beginning of period at Dec. 31, 2025 $ 94,875 $ 4 821,319 (726,448)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (50,497)      
Balance at end of period (in shares) at Jun. 30, 2026 40,628,000 40,628,000    
Balance at end of period at Jun. 30, 2026 $ 211,532 $ 4 988,473 (776,945)
Balance at beginning of period (in shares) at Mar. 31, 2026   36,767,000    
Balance at beginning of period at Mar. 31, 2026 80,805 $ 4 836,912 (756,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 4,609   4,609  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   89,000    
Issuance of common stock upon exercise of stock options 798   798  
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 333   333  
Stock Issued During Period, Shares, Warrants   7,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   209,000    
Issuance of common stock (in shares)   3,556,000    
Issuance of common stock 145,821   145,821  
Net loss $ (20,834)     (20,834)
Balance at end of period (in shares) at Jun. 30, 2026 40,628,000 40,628,000    
Balance at end of period at Jun. 30, 2026 $ 211,532 $ 4 $ 988,473 $ (776,945)